Marco Alings

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf et al. · New England Journal of Medicine · 2009 · 11.1K citations · Full text

Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation

Hein Heidbüchel, Peter Verhamme, Marco Alings et al. · EP Europace · 2015 · 1.1K citations

Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation

John W. Eikelboom, Lars Wallentin, Stuart J. Connolly et al. · Circulation · 2011 · 1.1K citations · Full text

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial

Lars Wallentin, Salim Yusuf, Michael D. Ezekowitz et al. · The Lancet · 2010 · 1K citations

Thrombosis, Venous Thrombosis, Cardiovascular Disease +13

European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation

Hein Heidbüchel, Peter Verhamme, Marco Alings et al. · EP Europace · 2013 · 790 citations · Full text

Hypertension, Non-valvular Atrial Fibrillation, Pharmacotherapy +17